Browse by category

GLP-1 coverage in employer plans could double in 2024

Findings from a recent employer survey on sentiment and adoption of GLP-1 medications by Accolade and Savanta on sentiment and adoption...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

6 days ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

6 days ago

Racial and ethnic groups face barriers to obtaining OMMs

6 days ago

Weekly Digest